Use caution Drug recall · FDA · Published March 23, 2022

Preferred Pharma Recalls Clobetasol Lotion Due to CGMP Deviations

Preferred Pharmaceuticals recalls 1568 bottles of Clobetasol Propionate Lotion due to CGMP deviations. Check lot numbers and expiration dates for details.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0768-2022Drug Preferred Pharmaceuticals ›

Use caution until it’s fixed

CGMP Deviations: all products within expiry are being recalled because the manufacturing firm, Teligent Pharma, Inc. is discontinuing its stability study program.

Take action

Contact the company

Recalling firmPreferred Pharmaceuticals, Inc.1250 N Lakeview Ave Ste O · Anaheim, CA 92807-1801

✎ GovInfoNow plain-language explainer

Preferred Pharmaceuticals, Inc. is recalling 1,568 bottles of Clobetasol Propionate Lotion 0.05% because the manufacturer, Teligent Pharma, Inc., is discontinuing its stability study program. This recall covers all products within their expiry dates due to Current Good Manufacturing Practice (CGMP) deviations. The affected items were distributed in Illinois. Read more at govinfonow.com/recall/35056-preferred-pharma-recalls-clobetasol-lotion-due-to-cgmp-deviations.

Source Summary by GovInfoNow · govinfonow.com/recall/35056-preferred-pharma-recalls-clobetasol-lotion-due-to-cgmp-deviations · Updated October 10, 2026 · FDA enforcement record: FDA #D-0768-2022

Cite this page

“Preferred Pharma Recalls Clobetasol Lotion Due to CGMP Deviations.” GovInfoNow, updated October 10, 2026. https://govinfonow.com/recall/35056-preferred-pharma-recalls-clobetasol-lotion-due-to-cgmp-deviations. Based on FDA recall #D-0768-2022 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0768-2022%22&limit=1).

The FDA announced on March 23, 2022, that Preferred Pharmaceuticals, Inc. is recalling Clobetasol Propionate Lotion due to CGMP deviations. The company initiated the voluntary Class II recall because its manufacturer, Teligent Pharma, Inc., is discontinuing its stability study program.

How to tell if you have it

Brand: Preferred Pharmaceuticals
Product: Clobetasol Propionate Lotion 0.05%, Generic for Temovate
Size: 118 mL bottle
Manufacturer: Teligent Pharma, Inc.
NDC: 68788-7768-01
Lot codes: A0721O, A1421Y, A2121G, A2821D, B0421H, B0421I, B0521U, B1121G, B1921C, C0421B, C1821N, L0120F, L2320O, L3020T (Exp. 4/30/2022); B2521A, C1121S, C2521U, D0121S, D0921B, D1421B, D2921C, E0721A (Exp. 10/31/2022); D2221A (Exp. 12/31/2022)
Distribution: Illinois
Units affected: 1568 bottles

The hazard

According to the FDA, the recall addresses CGMP deviations because the manufacturing firm, Teligent Pharma, Inc., is discontinuing its stability study program for all products within their expiry dates.

Context

GovInfoNow's records show Preferred Pharmaceuticals, Inc. has 32 other recalls on record since August 15, 2018. Other recent recalls of similar products include Preferred Pharma Recalls Lidocaine Ointment Due to Content Issues (September 28, 2026), Geri-Care Eye Drops Recalled for Sterility Risk (March 25, 2026), and Preferred Pharma Recalls Ondansetron ODT Due to Defective Seals (November 17, 2025). Other recent recalls of similar products include Wells Pharma Fentanyl Citrate Injectable Solution Recall: Cgmp Deviations (April 1, 2026), Baxter Clindamycin Injection Recall: CGMP Deviations Risk (August 6, 2026), and Blossom Pharmaceuticals Globe Clotrimazole Cream Recall: Cgmp Deviations (October 31, 2025).

How to tell if you have this one

Look for a 118 mL Rx-only bottle labeled 'Clobetasol Propionate Lotion 0.05%, Generic for Temovate' manufactured by Teligent Pharma, Inc. and distributed by Preferred Pharmaceuticals, Inc. Check the NDC 68788-7768-01 and verify if your lot number is one of: A0721O, A1421Y, A2121G, A2821D, B0421H, B0421I, B0521U, B1121G, B1921C, C0421B, C1821N, L0120F, L2320O, L3020T (Exp: 4/30/2022); B2521A, C1121S, C2521U, D0121S, D0921B, D1421B, D2921C, E0721A (Exp: 10/31/2022); or D2221A (Exp: 12/31/2022).

Brand
Preferred Pharmaceuticals
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Your Bottle
Verify if your bottle matches the NDC, lot numbers, and expiration dates listed in the recall record.
Contact Your Pharmacist
Speak with your pharmacist or healthcare provider to determine if you have a recalled unit and what steps to take next.

Where it went and when

Where it was distributed

Distributed in Illinois.

FDA distribution: “IL” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Illinois.

Recall timeline

FDA terminated this recall 13 months after the firm started it.

Mar 23, 2022Firm started the recall
Apr 14, 2022FDA classified it Class II
Apr 20, 2022Published in FDA’s Enforcement Report
May 4, 2023FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Preferred Pharmaceuticals recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/35056-preferred-pharma-recalls-clobetasol-lotion-due-to-cgmp-deviations">Preferred Pharma Recalls Clobetasol Lotion Due to CGMP Deviations (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0768-2022 (March 23, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0768-2022 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.